Loading...
XKRX002760
Market cap45mUSD
Jan 10, Last price  
1,131.00KRW
1D
0.80%
1Q
-24.35%
Jan 2017
-2.16%
Name

Bolak Co Ltd

Chart & Performance

D1W1MN
XKRX:002760 chart
P/E
78.98
P/S
1.45
EPS
14.32
Div Yield, %
0.62%
Shrs. gr., 5y
-0.49%
Rev. gr., 5y
6.74%
Revenues
46.77b
-3.43%
15,065,090,00018,659,886,00021,537,274,00023,189,664,00025,276,708,42031,403,500,82030,749,425,97031,151,277,34031,066,713,87035,708,601,32033,456,068,71033,763,266,62036,123,805,07038,292,697,00039,763,912,51048,434,715,67046,773,797,120
Net income
858m
-72.05%
-1,240,786,000193,915,000463,709,000656,606,000124,894,3701,921,287,990719,938,8302,079,543,210-172,455,6403,032,427,1901,238,718,5301,105,109,210648,533,670394,508,5001,694,987,5503,069,106,050857,813,413
CFO
1.52b
-40.24%
397,219,000-423,441,000392,329,0001,599,640,000784,278,2403,794,667,9901,992,366,6203,630,424,3603,184,487,1405,452,115,150705,777,3103,377,011,7501,463,212,9302,029,892,9801,177,596,8102,548,454,1401,522,906,470
Dividend
Dec 27, 20235 KRW/sh

Profile

Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, and dairy flavoring products; active pharmaceutical ingredients, such as dry extract powders, viscous extracts, fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Ca-CMC; health subsidiary foods, including green tea extracts, soy isoflavones, and ginseng extracts; and food coloring products. It also provides gum base products; cosmetic ingredients; fragrances for use in perfumes, cosmetics, hair products, daily supplies, toilet soaps, candles, and industrial products; and other products, such as sweeteners, surfactants, whitening agents, preservatives, antioxidants, abrasives, thickening agents, thickeners, caffeine, and baking powder. Bolak Company Limited was founded in 1959 and is headquartered in Hwaseong-si, South Korea.
URL
http://www.bolak.co.kr/
IPO date
Nov 30, 1989
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
46,773,797
-3.43%
48,434,716
21.81%
Cost of revenue
43,411,598
42,272,458
Unusual Expense (Income)
NOPBT
3,362,199
6,162,258
NOPBT Margin
7.19%
12.72%
Operating Taxes
(134,048)
319,944
Tax Rate
5.19%
NOPAT
3,496,247
5,842,314
Net income
857,813
-72.05%
3,069,106
81.07%
Dividends
(419,300)
(299,500)
Dividend yield
0.53%
0.31%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
79,984
3,078,940
Long-term debt
2,120,484
247,009
Deferred revenue
Other long-term liabilities
83,297
65,107
Net debt
(1,095,007)
(4,864,481)
Cash flow
Cash from operating activities
1,522,906
2,548,454
CAPEX
(569,030)
(649,749)
Cash from investing activities
108,573
(915,374)
Cash from financing activities
(1,498,240)
(382,999)
FCF
3,933,145
4,744,501
Balance
Cash
3,295,475
3,162,236
Long term investments
5,028,194
Excess cash
956,785
5,768,694
Stockholders' equity
38,346,508
38,350,517
Invested Capital
50,058,449
45,544,566
ROIC
7.31%
12.99%
ROCE
6.30%
11.45%
EV
Common stock shares outstanding
59,900
59,900
Price
1,309.00
-18.70%
1,610.00
-18.69%
Market cap
78,409,100
-18.70%
96,439,000
-18.69%
EV
77,314,093
91,574,519
EBITDA
5,253,064
8,144,202
EV/EBITDA
14.72
11.24
Interest
89,692
67,512
Interest/NOPBT
2.67%
1.10%